Clinical Trials Directory

Trials / Completed

CompletedNCT04940793

Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Beaver-Visitec International, Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the visual performance and refractive predictability with the diffractive toric Finevision POD FT IOL. Predicted and achieved visual outcomes, visual performance at near, intermediate and far distance as well as photic phenomena, rotational stability and spectacle independence will be investigated. The follow-up period is 3 months after which vision and refraction should have stabilized.

Detailed description

This prospective study was performed to investigate the visual performance and refractive predictability with the diffractive toric Finevision POD FT IOL (PhyslOL, Belgium). Predicted and achieved visual outcomes, visual performance at near, intermediate and far distance as well as rotational stability have been analyzed. The follow-up period was 6 months. All IOL implantations were performed by the investigators Dr. Filomena Ribeiro and Dr. Tiago B Ferreira (Hospital da Luz, Lisboa, Portugal). The study population consists of patients undergoing routine cataract surgery. The study patients underwent binocular implantation of Finevision IOLs depending on the preoperative amount of corneal astigmatism (either a toric POD FT IOL in both eyes or a POD FT in the study eye and a non-toric POD F IOL in the contralateral eye).

Conditions

Interventions

TypeNameDescription
DEVICEPOD FTCataract surgery

Timeline

Start date
2017-07-18
Primary completion
2019-01-23
Completion
2019-01-23
First posted
2021-06-28
Last updated
2021-06-28

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT04940793. Inclusion in this directory is not an endorsement.